Selected article for: "SARS CoV sequence identity and sequence identity"
Author: Sangeun Jeon; Meehyun Ko; Jihye Lee; Inhee Choi; Soo Young Byun; Soonju Park; David Shum; Seungtaek Kim
Title: Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
  • Document date: 2020_3_20
    • ID: 5f95gve3_7
    Snippet: We screened approximately 3,000 FDA-and IND-approved drug library against SARS-CoV to identify antiviral drug candidates (manuscript in preparation). Since the SARS-CoV and SARS-CoV-2 are very similar (79.5% sequence identity) 1 , the drugs which show antiviral activity against SARS-CoV are expected to show similar extent of antiviral activity against SARS-CoV-2......
    Document: We screened approximately 3,000 FDA-and IND-approved drug library against SARS-CoV to identify antiviral drug candidates (manuscript in preparation). Since the SARS-CoV and SARS-CoV-2 are very similar (79.5% sequence identity) 1 , the drugs which show antiviral activity against SARS-CoV are expected to show similar extent of antiviral activity against SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • antiviral activity and drug library: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral activity and SARS antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and SARS CoV antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and SARS CoV antiviral activity drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antiviral activity and sequence identity: 1, 2, 3, 4, 5, 6
    • antiviral activity and similar extent: 1, 2, 3, 4, 5
    • antiviral drug candidate and drug candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug candidate and SARS antiviral activity: 1, 2, 3
    • antiviral drug candidate and SARS CoV antiviral activity: 1, 2, 3
    • antiviral drug candidate and SARS CoV antiviral activity drug: 1
    • drug candidate and SARS antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • drug candidate and SARS CoV antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • drug candidate and SARS CoV antiviral activity drug: 1
    • drug candidate and sequence identity: 1, 2
    • drug library and SARS antiviral activity: 1, 2, 3, 4
    • drug library and SARS CoV antiviral activity: 1, 2, 3, 4